Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

1737 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Quality measures for care of patients with restless legs syndrome: 2025 update after measure maintenance

Lloyd RM, Crawford T, Donald R, Gray DD, Healy WJ, Junna MR, Lewin D, Revana A, Schutte-Rodin S.

J Clin Sleep Med. 2025 Dec 1;21(12):2205-2211. doi: 10.5664/jcsm.11894.

Progressive muscle relaxation versus manual lymphatic drainage on restless leg syndrome and sleep quality in hemodialysis patients: Randomized Controlled Trial

Elfahl AM, Elfeky HM.

J Bodyw Mov Ther. 2025 Oct;44:549-557. doi: 10.1016/j.jbmt.2025.06.015. Epub 2025 Jun 18.

Exploring the pathophysiology of restless leg syndrome: focus on white matter structure and function

Wang Z, Li Z, Wang J, Gao J, Li Y.

Postgrad Med J. 2025 Jun 22;101(1197):596-602. doi: 10.1093/postmj/qgae156.

Sleep-Related Disorders in Patients with CKD and Kidney Transplant Recipients

Vendeville N, Mucsi I, Molnar MZ.

Clin J Am Soc Nephrol. 2025 Oct 1;20(10):1446-1460. doi: 10.2215/CJN.0000000728. Epub 2025 Apr 9.

Pilot study of Pitolisant, a histamine-3 inverse agonist, as adjunct therapy for refractory restless legs syndrome

Ondo WG.

Sleep Med. 2025 Sep;133:106634. doi: 10.1016/j.sleep.2025.106634. Epub 2025 Jun 10.

Restless legs syndrome and inflammatory bowel disease: A systematic review and meta-analysis

Banihashemian SM, Pirzad S, Poudineh M, Sharafi F, JamshidiRastabi S, Banihashemian SA, Jafari SE, Jafari M, Tamaddon Y, Najafi S, Mosayyebi F, Ashrafi S, Moftakhar A, Vahed IE, Rahmanian M.

IBRO Neurosci Rep. 2025 Oct 30;19:862-871. doi: 10.1016/j.ibneur.2025.10.019. eCollection 2025 Dec.

Predictors of poor sleep quality in multiple sclerosis: The independent role of anxiety and restless legs syndrome

Alis C, Kose N, Sen Kilic S, Genc G, Bulut S.

Sleep Med. 2025 Oct;134:106691. doi: 10.1016/j.sleep.2025.106691. Epub 2025 Jul 17.

Tuberculosis and sleep - An underexplored association?

Layek A, Suri TM.

Indian J Tuberc. 2025;72 Suppl 1:S91-S93. doi: 10.1016/j.ijtb.2025.02.007. Epub 2025 Feb 7.

[Sleep and neurodevelopment: a timely subject]

Langelet C, Schröder CM.

Biol Aujourdhui. 2025;219(1-2):15-23. doi: 10.1051/jbio/2025006. Epub 2025 Jul 22.

Treatment of insomnia, restless legs, cramps, and pain associated with chronic kidney disease: results from a multinational survey of kidney supportive care practice

Nalankilli K, Stallworthy E, Ducharlet K, Hole BD, O'Hara DV, Agarwal N, Snead CM, Caskey FJ, Smyth B.

BMC Nephrol. 2025 Apr 23;26(1):204. doi: 10.1186/s12882-025-04107-1.

Insomnia in ambulatory care: A clinical review

Dopheide JA, Roth WR, Chu MKL.

Am J Health Syst Pharm. 2025 Mar 7;82(6):265-284. doi: 10.1093/ajhp/zxae255.

Unraveling the pathophysiology of restless legs syndrome from multimodal MRI techniques: A systematic review

Pani T, Mogavero MP, Ferri R, Lanza G.

Sleep Med. 2025 Jan;125:31-56. doi: 10.1016/j.sleep.2024.11.020. Epub 2024 Nov 13.

The association between restless legs syndrome and chronic venous insufficiency: a systematic review

Alyahya MA, Almansour R, Altamimi A, AlAkeel N.

J Med Life. 2025 Oct;18(10):946-952. doi: 10.25122/jml-2025-0075.

Subclinical Augmentation in Relation to Previous Dopaminergic Treatment in Patients with Restless Legs Syndrome: A Post Hoc Analysis of Two Randomized, Placebo-Controlled, Crossover Trials

Garcia-Borreguero D, Anguizola D, Carvallo C, Lopez A, Garcia Aragón A, Moncada B, Ferré S.

CNS Drugs. 2025 Aug;39(8):779-793. doi: 10.1007/s40263-025-01192-6. Epub 2025 Jun 4.

Pharmacological Strategies for the Treatment of Restless Legs Syndrome

Anguizola D, Garcia Aragón A, Lopez Jimenez A, Sainz V, Garcia-Borreguero D.

Curr Neurol Neurosci Rep. 2025 Aug 19;25(1):60. doi: 10.1007/s11910-025-01445-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias